510(k) device
Niox Vero
Circassia AB · System, Test, Breath Nitric Oxide (MXA, Class II) · First FDA decision Nov 22, 2017, newest Nov 22, 2017Asthma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Niox Vero"
MAUDE reports
0
Brand "Niox Vero", since 2015
PubMed studies
36
Mentioning "Niox Vero"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Niox Vero
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- NIOX VERO510(k)
K170983 · Decided Nov 22, 2017 · 233 days after receipt
Device type: System, Test, Breath Nitric Oxide (MXA) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Niox Vero", any status and sponsor, newest update first.
No registered device study names "Niox Vero".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Niox Vero", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MXA
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Niox Vero"[tiab]. The summary above synthesizes these.
- Device comparison study to measure nasal nitric oxide in relation to primary ciliary dyskinesia.
Jõgi NO, Ersson K, Alving K, et al. · J Breath Res · 2023Research Support, Non-U.S. Gov't
- The comparison of two exhaled nitric oxide analyzers: NIOX VERO and SUNVOU-CA2122.
Lei W, Li F, Tang XM, et al. · J Breath Res · 2021Research Support, Non-U.S. Gov't
- Fractional exhaled nitric oxide measurement: Comparison between the Sunvou-CA2122 analyzer and the NIOX VERO analyzer.
Huang T, Liu B, Yang D, et al. · J Asthma · 2021Comparative Study, Research Support, Non-U.S. Gov't
- Validation of a new portable system containing both FeNO analysis and spirometry measurement.
Li Y, Huang K, Li W, et al. · Front Med (Lausanne) · 2023
- Fractional Exhaled Nitric Oxide as a Marker of Mucosal Inflammation in Chronic Rhinosinusitis.
Olonisakin TF, Moore JA, Barel S, et al. · Am J Rhinol Allergy · 2022
- Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath.
Harnan SE, Tappenden P, Essat M, et al. · Health Technol Assess · 2015Research Support, Non-U.S. Gov't, Systematic Review
- Comparison of fractional exhaled nitric oxide levels measured by different analyzers produced by different manufacturers.
Saito J, Kikuchi M, Fukuhara A, et al. · J Asthma · 2020Comparative Study, Observational Study
- Comparative validation of handheld fractional exhaled nitric oxide measurements.
van Deelen S, Tramper-Stranders GA, Hendriks RW, et al. · Expert Rev Med Devices · 2025Comparative Study, Validation Study
- Assessing Nasal Nitric Oxide in Allergic Rhinitis: A Controversial Biomarker.
Louca N, Damianou D, Kostea N, et al. · Medicina (Kaunas) · 2025
- Measurement of Fractional Exhaled Nitric Oxide: Comparison of Three Different Analysers.
Korn S, Wilk M, Voigt S, et al. · Respiration · 2020Comparative Study
- Difference between two exhaled nitric oxide analyzers, NIOX VERO® electrochemical hand-held analyzer and NOA280i® chemiluminescence stationary analyzer.
Tanabe Y, Harada N, Ito J, et al. · J Asthma · 2019Comparative Study, Evaluation Study
- A comparative study of the RuiBreath and NIOX VERO analyzers for detecting fractional exhaled nitric oxide.
Liu Y, Chang X, Liang L, et al. · J Thorac Dis · 2021
Other devices of this type
Also filed under product code MXA.
- NIOX VERO Airway Inflammation MonitorAerocrine AB · 510(k) 2015
- Niox Mino Model 09-1000Aerocrine AB · 510(k) 2010
- Fenom Flo FeNO Monitoring SystemMgc Diagnostics Corporation · 510(k) 2025
- Vivatmo pro-SBosch Healthcare Solutions GmbH · 510(k) 2025
- Vivatmo proBosch Healthcare Solutions GmbH · 510(k) 2024
- Fenom ProCaire Diagnostics, Inc. · 510(k) 2023
- NObreath®Bedfont Scientific, Ltd. · 510(k) 2021
- Fenom Pro Nitric Oxide TestSpirosure, Inc. · 510(k) 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.